Depression Research and Treatment / 2011 / Article / Tab 4

Clinical Study

The Pharmacopsychometric Triangle to Illustrate the Effectiveness of T-PEMF Concomitant with Antidepressants in Treatment Resistant Patients: A Double-Blind, Randomised, Sham-Controlled Trial Revisited with Focus on the Patient-Reported Outcomes

Table 4

The LOCF analysis with HAM-D17.

HAM-D17Active T-PEMFSham T-PEMF
( )( )

Baseline21.29 (4.0)21.62 (3.6)
week 117.33 (5.1)*19.58 (3.3)
week 215.05 (3.2)*17.63 (4.9)
week 314.10 (4.5)**17.68 (4.9)
week 412.67 (5.6)**17.79 (4.0)
week 511.38 (6.5)**16.68 (4.4)

* .
** .

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.